Serial Number
79419090
Owner
Prothea Technologies LtdAttorney
Bruce S. LondaFiling Date
Jan 29, 2025
KRONOSCAN Trademark
Serial Number: 79419090
Trademark Classes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Bruce S. Londa Norris McLaughlin, P.A.
7 Times Square
21st Floor
New York, NY 10036
United States
Trademark Details
Filing Date
January 29, 2025
Registration Date
Not Registered
Goods & Services
Medical devices for use in treating or diagnosing lung cancer; medical apparatus, namely, microendoscopes, spectroscopes, fluorescence spectrometer, fluorescence-based diagnostic imager, laser ablation catheter; medical devices for use in diagnosing cancer; medical apparatus and instruments for the treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for use in diagnosing lung cancer; medical testing kits for diagnosing lung cancer; oncology instruments for medical use in treatment of lung cancer; apparatus for applying laser radiation for medical purposes; diagnostic imaging apparatus for medical use; apparatus for analyzing images for medical use; parts and fittings for all of the aforesaid goods
Medical services; medical services relating to cancer; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review, counselling, and patient networking; consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review; computer information services, namely, providing information on cancer and other diseases, oncology and disease management via a global computer network; medical services, namely, medical diagnostic testing, monitoring and reporting services; information, consultancy and advisory services relating to the aforesaid services.
Scientific services, namely, processing of fluorescent images; technological services, namely, processing of fluorescent images; scientific research; technological research in the field of fluorescence-based imaging; scientific and technological services, namely, research and design in the field of fluorescence-based imaging; medical research services; scientific research in the field of oncology; conducting and directing medical and scientific research in the field of cancer prevention, causes, symptoms, diagnosis, detection, treatment and prevention; design and development of image processing software; design and development of computer software for use with medical technology; electronic scanning of images; platform as a service (PaaS) featuring software platforms for transmission of images; information, consultancy and advisory services relating to the aforesaid services